Would love to hear more about this opinion.
What is different about the batches, or to put a different way: what aspects of the nanoviricides are difficult to make consistently, in your opinion?
Is it the base polymer, nanomicelle size, distribution of particle size, production of ligands, self-assembling of nanomicelles at larger batches, coupling of the ligands to the nanomicelle, simply a lack of standardized testing/controls, or what do your inside sources tell you about the problem? Or is this just some random guess?
How are they able to replicate results from multiple labs if the nanoviricides are not reproducible to make? Are you saying every test that has been done has been sent from one batch?
Market Data 
Markets 
AI
